4853 V (Oxybutynin 5 mg)
Pill imprint 4853 V has been identified as Oxybutynin chloride 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4853 V (Oxybutynin 5 mg)
- 5 mg
- 8.00 mm
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|63739-0195||McKesson Packaging Services|
|68084-0400||Amerisource Health Services|
|54569-1990||A S Medication Solutions LLC (repackager)|
|23490-6051||Palmetto State Pharmaceuticals Inc (repackager)|
|43063-0145||PDRX Pharmaceuticals Inc (repackager)|
|21695-0406||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about oxybutynin
- Oxybutynin extended-release tablets
- Oxybutynin gel
- Oxybutynin syrup
- Oxybutynin system
- More (4) »